CN106310369A - 一种组合物、含有该组合物的3d敷料及其制备方法 - Google Patents
一种组合物、含有该组合物的3d敷料及其制备方法 Download PDFInfo
- Publication number
- CN106310369A CN106310369A CN201610864801.1A CN201610864801A CN106310369A CN 106310369 A CN106310369 A CN 106310369A CN 201610864801 A CN201610864801 A CN 201610864801A CN 106310369 A CN106310369 A CN 106310369A
- Authority
- CN
- China
- Prior art keywords
- dressing
- fat
- compositions
- following component
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0033—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y10/00—Processes of additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y80/00—Products made by additive manufacturing
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Materials Engineering (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Manufacturing & Machinery (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
组分 | 含量 |
P3代脂肪干细胞(实施例1获得) | 0.9×105个/ml~1.1×105个/ml |
壳多糖 | 1.8~2.2% |
I型胶原 | 0.4~0.6% |
EGF | 4.5~5.5ng/mL |
人脂肪脱细胞基质冻干粉 | 2.5~3.5% |
Lonza(溶剂) | 余量 |
组分 | 含量 |
P3代脂肪干细胞(实施例1获得) | 4.5×105个/ml-5.5×105个/ml |
壳多糖 | 1.5-2.5% |
I型胶原 | 0.4-0.6% |
EGF | 4.5-5.5ng/mL |
人脂肪脱细胞基质冻干粉 | 4.5-5.5% |
Lonza(溶剂) | 余量 |
组分 | 含量 |
P3代脂肪干细胞(实施例1获得) | 1×105个/ml |
壳多糖 | 2% |
I型胶原 | 0.5% |
EGF | 5ng/mL |
人脂肪脱细胞基质冻干粉 | 3% |
Lonza(溶剂) | 余量 |
组分 | 含量 |
P3代脂肪干细胞(实施例1获得) | 4.5×105个/ml |
壳多糖 | 2% |
I型胶原 | 0.5% |
EGF | 5ng/mL |
人脂肪脱细胞基质冻干粉 | 5% |
Lonza(溶剂) | 余量 |
组分 | 含量 |
P3代脂肪干细胞(实施例1获得) | 1×106个/ml |
壳多糖 | 2% |
I型胶原 | 0.5% |
EGF | 5ng/mL |
人脂肪脱细胞基质冻干粉 | 5% |
Lonza(溶剂) | 余量 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610864801.1A CN106310369A (zh) | 2016-09-29 | 2016-09-29 | 一种组合物、含有该组合物的3d敷料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610864801.1A CN106310369A (zh) | 2016-09-29 | 2016-09-29 | 一种组合物、含有该组合物的3d敷料及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106310369A true CN106310369A (zh) | 2017-01-11 |
Family
ID=57821050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610864801.1A Pending CN106310369A (zh) | 2016-09-29 | 2016-09-29 | 一种组合物、含有该组合物的3d敷料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106310369A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109513037A (zh) * | 2018-11-14 | 2019-03-26 | 华中科技大学同济医学院附属协和医院 | 一种负载介孔生物玻璃的小肠粘膜下层创面敷料 |
CN110253876A (zh) * | 2019-05-22 | 2019-09-20 | 苏州瑞兴手外科技术应用研究所 | 基于3d打印框架控制的牵张力调控组织血管分支的方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102205146A (zh) * | 2011-04-12 | 2011-10-05 | 王影 | 干细胞修复材料、其制备方法及其应用 |
CN102933705A (zh) * | 2009-12-17 | 2013-02-13 | 金斯顿女王大学 | 去细胞化的脂肪组织 |
CN104548207A (zh) * | 2014-03-04 | 2015-04-29 | 四川大学华西医院 | 一种猪脂肪组织无细胞基质材料的制备方法 |
WO2015058318A1 (es) * | 2013-10-22 | 2015-04-30 | Universidad De Chile | Composición para acelerar o mejorar la cicatrización en heridas, y un método para acelerar o mejorar la cicatrización en heridas que comprende aplicar dicha composición |
CN104971380A (zh) * | 2014-04-11 | 2015-10-14 | 烟台隽秀生物科技有限公司 | 一种脱细胞基质修复凝胶及其制备新方法 |
CN105079859A (zh) * | 2015-08-20 | 2015-11-25 | 广州赛莱拉干细胞科技股份有限公司 | 一种敷料及其制备方法 |
CN105193847A (zh) * | 2015-09-15 | 2015-12-30 | 广州赛莱拉干细胞科技股份有限公司 | 一种含有脂肪干细胞的凝胶制剂及其制备方法和医用敷料 |
CN105688287A (zh) * | 2016-01-26 | 2016-06-22 | 深圳爱生再生医学科技有限公司 | 用于治疗皮肤创伤的羊膜贴片及其制备方法 |
-
2016
- 2016-09-29 CN CN201610864801.1A patent/CN106310369A/zh active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102933705A (zh) * | 2009-12-17 | 2013-02-13 | 金斯顿女王大学 | 去细胞化的脂肪组织 |
CN102205146A (zh) * | 2011-04-12 | 2011-10-05 | 王影 | 干细胞修复材料、其制备方法及其应用 |
WO2015058318A1 (es) * | 2013-10-22 | 2015-04-30 | Universidad De Chile | Composición para acelerar o mejorar la cicatrización en heridas, y un método para acelerar o mejorar la cicatrización en heridas que comprende aplicar dicha composición |
CN104548207A (zh) * | 2014-03-04 | 2015-04-29 | 四川大学华西医院 | 一种猪脂肪组织无细胞基质材料的制备方法 |
CN104971380A (zh) * | 2014-04-11 | 2015-10-14 | 烟台隽秀生物科技有限公司 | 一种脱细胞基质修复凝胶及其制备新方法 |
CN105079859A (zh) * | 2015-08-20 | 2015-11-25 | 广州赛莱拉干细胞科技股份有限公司 | 一种敷料及其制备方法 |
CN105193847A (zh) * | 2015-09-15 | 2015-12-30 | 广州赛莱拉干细胞科技股份有限公司 | 一种含有脂肪干细胞的凝胶制剂及其制备方法和医用敷料 |
CN105688287A (zh) * | 2016-01-26 | 2016-06-22 | 深圳爱生再生医学科技有限公司 | 用于治疗皮肤创伤的羊膜贴片及其制备方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109513037A (zh) * | 2018-11-14 | 2019-03-26 | 华中科技大学同济医学院附属协和医院 | 一种负载介孔生物玻璃的小肠粘膜下层创面敷料 |
CN109513037B (zh) * | 2018-11-14 | 2021-09-17 | 华中科技大学同济医学院附属协和医院 | 一种负载介孔生物玻璃的小肠粘膜下层创面敷料 |
CN110253876A (zh) * | 2019-05-22 | 2019-09-20 | 苏州瑞兴手外科技术应用研究所 | 基于3d打印框架控制的牵张力调控组织血管分支的方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106109496B (zh) | 人脐带间充质干细胞提取物冻干粉及制备方法 | |
CN101757691B (zh) | 一种组织工程角膜的制备方法 | |
CN108525021A (zh) | 基于3d打印的含血管及毛囊结构组织工程皮肤及其制备方法 | |
CN104324053B (zh) | 一种快速愈合犬创伤组织的犬干细胞分泌因子修复液 | |
CN106267357A (zh) | 一种修复骨软骨组织的双层复合水凝胶、制备方法及应用 | |
CN102743796B (zh) | 用聚乙烯醇制成的丝素蛋白多孔支架及其制备方法和用途 | |
CN101549171A (zh) | 一种ⅱ型胶原海绵支架及其用途 | |
CN106492194A (zh) | 一种干细胞外泌体制剂及其制备方法和应用 | |
CN110564682A (zh) | 一种大规模生产人脂肪间充质干细胞外泌体的方法 | |
CN105013014A (zh) | 一种无细胞基质生物材料的制备方法和用途 | |
CN110938587A (zh) | 一种表皮干细胞混悬液的制备方法及其应用 | |
CN105477626A (zh) | 混合干细胞制剂及其制备方法 | |
CN104250655A (zh) | Bmp-2/vegf165双基因修饰的骨髓间充质干细胞及其制备方法 | |
CN106421917A (zh) | 制备用于软骨损伤修复的组合物的方法 | |
Pu et al. | Injectable human decellularized adipose tissue hydrogel containing stem cells enhances wound healing in mouse | |
CN105412986B (zh) | 小肠黏膜下层载药补片及其制备方法和应用 | |
CN106310369A (zh) | 一种组合物、含有该组合物的3d敷料及其制备方法 | |
CN107823699A (zh) | 止血防粘连膜及其制备方法 | |
CN107693844A (zh) | 一种组合物凝胶与应用 | |
CN109771694A (zh) | 自组装多肽纳米纤维水凝胶支架材料的制备方法及应用 | |
CN106474156A (zh) | 组合物在制备药物中的用途 | |
CN107236032B (zh) | 一种从脐带组织中提取复合细胞因子的方法 | |
CN101088569A (zh) | 一种注射用人体皮肤填充剂及其制备方法 | |
CN101029303B (zh) | 一种诱导干细胞向软骨分化的物质和方法 | |
CN106282101A (zh) | 一种促进人羊膜间充质干细胞向软骨细胞分化的方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Chen Haijia Inventor after: Ge Xiaohu Inventor after: Wang Yifei Inventor after: Zhao Mengmeng Inventor after: Wang Xiaoyan Inventor after: Wang Dianliang Inventor after: He Yong Inventor before: Chen Haijia Inventor before: Ge Xiaohu Inventor before: Wang Yifei Inventor before: Zhao Mengmeng Inventor before: Wang Xiaoyan |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170111 |